Parsifal Capital Management, LP 13F: Quarter-over-Quarter Portfolio Changes
Parsifal Capital Management, LP reported a disclosed portfolio value of approximately $774.6 million in its latest SEC Form 13F-HR filing for Q1 2026, down 22.0% quarter on quarter. Over the quarter, the fund initiated 5 new positions, bought more shares in 1 holding, trimmed 11 holdings, and exited 3 positions.
Parsifal Capital Management, LP's top buy was a new stake in Compass INC (COMP) , equal to 11.2% of the disclosed portfolio. Its top sell was Teva Pharmaceutical Inds LTD (TEVA) . The fund exited the position completely after it had accounted for 8.9% of the previous portfolio.
New PositionsQ1 2026
Securities disclosed for the first time in Q1 2026 that were not present in the prior 13F-HR filing.
| Company | Ticker | Initial Portfolio Weight | History |
|---|---|---|---|
| COMPASS INC | COMP | 11.2% | History → |
| AKAMAI TECHNOLOGIES INC | AKAM | 7.1% | History → |
| CAESARS ENTERTAINMENT INC NE | CZR | 6.6% | History → |
| JUMIA TECHNOLOGIES AG | JMIA | 3.1% | Holders → |
| TERADATA CORP DEL | TDC | 2.4% | Holders → |
Top BuysQ1 2026
The fund's top buys among existing positions in Q1 2026. Ranked by portfolio-weight impact, with the percentage of additional shares shown separately.
| Company | Ticker | Portfolio Weight Change | More Shares | History |
|---|---|---|---|---|
| AVEPOINT INC | AVPT | +-0.6% | +1.6% | Holders → |
Top SellsQ1 2026
Showing the top 10 sells among 11 existing positions where the fund sold shares in Q1 2026. Ranked by portfolio-weight impact. Full exits are listed separately.
| Company | Ticker | Portfolio Weight Change | Shares Sold | History |
|---|---|---|---|---|
| GLOBUS MED INC | GMED | -6.4% | 68.3% | Holders → |
| VIAVI SOLUTIONS INC | VIAV | -0.6% | 62.0% | History → |
| LOUISIANA PAC CORP | LPX | -0.6% | 49.0% | Holders → |
| GXO LOGISTICS INCORPORATED | GXO | -1.9% | 41.0% | History → |
| ATMUS FILTRATION TECHNOLOGIE | ATMU | -0.7% | 36.1% | History → |
| 3M COMPANY | MMM | -1.7% | 35.8% | Holders → |
| SHARKNINJA INC | SN | -2.7% | 33.9% | History → |
| ALBERTSONS COS INC | ACI | -0.5% | 30.3% | Holders → |
| AXALTA COATING SYS LTD | AXTA | -0.4% | 14.7% | History → |
| HILTON GRAND VACATIONS INC | HGV | -0.2% | 12.7% | History → |
Full ExitsQ1 2026
Positions present in the prior 13F-HR filing that no longer appear in Q1 2026.
| Company | Ticker | Last-Reported Portfolio Weight |
|---|---|---|
| TEVA PHARMACEUTICAL INDS LTD | TEVA | 8.9% |
| UNITEDHEALTH GROUP | UNH | 5.0% |
| CORE SCIENTIFIC INC NEW | CORZ | 1.8% |
Net Portfolio Value ChangeQ1 2026
- $1.0BPrior quarter
- $0.8BCurrent quarter
- $-0.2BNet delta
- -22.0%% change
Methodology & FAQ
How Parsifal Capital Management, LP Quarterly Changes Are Computed
All deltas are sourced from sequential SEC Form 13F-HR filings for Parsifal Capital Management, LP: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description — including how confidential treatment filings are handled — is documented in the Methodology.
What stocks did Parsifal Capital Management, LP buy in Q1 2026?
In Q1 2026, Parsifal Capital Management, LP initiated 5 new positions (COMPASS INC (COMP), AKAMAI TECHNOLOGIES INC (AKAM), CAESARS ENTERTAINMENT INC NE (CZR), JUMIA TECHNOLOGIES AG (JMIA), TERADATA CORP DEL (TDC)); bought more shares of AVEPOINT INC (AVPT).
What stocks did Parsifal Capital Management, LP sell in Q1 2026?
In Q1 2026, Parsifal Capital Management, LP fully sold 3 positions (TEVA PHARMACEUTICAL INDS LTD (TEVA), UNITEDHEALTH GROUP (UNH), CORE SCIENTIFIC INC NEW (CORZ)); reduced holdings in GLOBUS MED INC (GMED), VIAVI SOLUTIONS INC (VIAV), LOUISIANA PAC CORP (LPX), GXO LOGISTICS INCORPORATED (GXO), ATMUS FILTRATION TECHNOLOGIE (ATMU) — the largest 5 of 11 reductions.
Which positions did Parsifal Capital Management, LP initiate in Q1 2026?
Parsifal Capital Management, LP established 5 new positions in Q1 2026: COMPASS INC (COMP, 11.2%), AKAMAI TECHNOLOGIES INC (AKAM, 7.1%), CAESARS ENTERTAINMENT INC NE (CZR, 6.6%), JUMIA TECHNOLOGIES AG (JMIA, 3.1%), TERADATA CORP DEL (TDC, 2.4%).
Which existing positions saw the largest allocation increases for Parsifal Capital Management, LP in Q1 2026?
Of 1 existing position with share-count increases in Q1 2026, the largest were: AVEPOINT INC (AVPT, +-0.6% weight, +1.6% shares).
Which positions did Parsifal Capital Management, LP fully exit in Q1 2026?
Parsifal Capital Management, LP fully exited 3 positions in Q1 2026: TEVA PHARMACEUTICAL INDS LTD (TEVA, last-reported weight 8.9%), UNITEDHEALTH GROUP (UNH, last-reported weight 5.0%), CORE SCIENTIFIC INC NEW (CORZ, last-reported weight 1.8%).
Which existing positions saw the largest allocation reductions for Parsifal Capital Management, LP in Q1 2026?
Of 11 existing positions with share-count reductions in Q1 2026, the largest were: GLOBUS MED INC (GMED, -6.4% weight, -68.3% shares), VIAVI SOLUTIONS INC (VIAV, -0.6% weight, -62.0% shares), LOUISIANA PAC CORP (LPX, -0.6% weight, -49.0% shares), GXO LOGISTICS INCORPORATED (GXO, -1.9% weight, -41.0% shares), ATMUS FILTRATION TECHNOLOGIE (ATMU, -0.7% weight, -36.1% shares), 3M COMPANY (MMM, -1.7% weight, -35.8% shares), SHARKNINJA INC (SN, -2.7% weight, -33.9% shares), ALBERTSONS COS INC (ACI, -0.5% weight, -30.3% shares), AXALTA COATING SYS LTD (AXTA, -0.4% weight, -14.7% shares), HILTON GRAND VACATIONS INC (HGV, -0.2% weight, -12.7% shares).
Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?
No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.